Legend Biotech Co News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Legend biotech co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Legend Biotech Co Today - Breaking & Trending Today

Legend Biotech (NASDAQ:LEGN) Shares Down 6%

Legend Biotech (NASDAQ:LEGN) Shares Down 6%
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

United States , Raymond James , Sumitomo Mitsui Trust Holdings Inc , Royal Bank , Massachusetts Financial Services Co , Cantor Fitzgerald , Legend Biotech Corporation , Timessquare Capital Management , Legend Biotech Co , Deutsche Bank Aktiengesellschaft , Legend Biotech , Get Free Report , Bank Aktiengesellschaft , Biotech Stock Down , Financial Services , Square Capital Management , Mitsui Trust Holdings , Adage Capital Partners , Capital Partners , Biotech Corporation , Legend Biotech Daily ,

Q4 2025 EPS Estimates for Legend Biotech Co. Decreased by Analyst (NASDAQ:LEGN)

Legend Biotech Co. (NASDAQ:LEGN – Free Report) – Research analysts at HC Wainwright lowered their Q4 2025 earnings per share (EPS) estimates for shares of Legend Biotech in a note issued to investors on Friday, May 24th. HC Wainwright analyst M. Kapoor now expects that the company will earn $0.10 per share for the quarter, […] ....

United States , Raymond James , Us Bancorp , Legend Biotech Co , Royal Bank , Deutsche Bank Aktiengesellschaft , Legend Biotech Corporation , American International Group Inc , Vanguard Personalized Indexing Management , Cantor Fitzgerald , Avior Wealth Management , Legend Biotech , Free Report , Bank Aktiengesellschaft , Get Free Report , Wealth Management , Personalized Indexing Management , Retirement System , American International Group , International Group , Biotech Corporation , Legend Biotech Daily ,

HC Wainwright Research Analysts Decrease Earnings Estimates for Legend Biotech Co. (NASDAQ:LEGN)

Legend Biotech Co. (NASDAQ:LEGN – Free Report) – Investment analysts at HC Wainwright decreased their Q4 2025 earnings per share (EPS) estimates for Legend Biotech in a report released on Friday, May 24th. HC Wainwright analyst M. Kapoor now anticipates that the company will post earnings per share of $0.10 for the quarter, down from […] ....

United States , Raymond James , Vanguard Personalized Indexing Management , Avior Wealth Management , Us Bancorp , American International Group Inc , Legend Biotech Co , Legend Biotech Company Profile , Legend Biotech Corporation , Cantor Fitzgerald , Royal Bank , Legend Biotech , Free Report , Get Free Report , Wealth Management , Personalized Indexing Management , Retirement System , American International Group , International Group , Biotech Corporation , Legend Biotech Daily ,

Legend Biotech (LEGN) – Investment Analysts' Recent Ratings Changes

A number of firms have modified their ratings and price targets on shares of Legend Biotech (NASDAQ: LEGN) recently: 5/24/2024 – Legend Biotech had its price target lowered by analysts at HC Wainwright from $86.00 to $73.00. They now have a “buy” rating on the stock. 5/23/2024 – Legend Biotech is now covered by analysts […] ....

United States , Royal Bank , Legend Biotech Corporation , Kokusai Asset Management Co , Cantor Fitzgerald , Mitsubishi Ufj , Legend Biotech Co , News Ratings For Legend Biotech Co Daily , Jump Financial , Deutsche Bank Aktiengesellschaft , Barclays Plc , Swiss National Bank , Legend Biotech , Deutsche Bank , Get Free Report , Retirement System , Asset Management , National Bank , Biotech Corporation , Legend Biotech Co Daily ,

Westfield Capital Management Co. LP Boosts Position in Legend Biotech Co. (NASDAQ:LEGN)

Westfield Capital Management Co. LP grew its position in shares of Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 6.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,776,247 shares of the company’s stock after purchasing an additional 108,097 […] ....

United States , Handelsinvest Investeringsforvaltning , Deutsche Bank Aktiengesellschaft , Cantor Fitzgerald , Legend Biotech Corporation , Legend Biotech Co , Westfield Capital Management Co , Financial Services Group Inc , Vanguard Personalized Indexing Management , Daiwa Securities Group Inc , Exchange Commission , Avior Wealth Management , Westfield Capital Management , Legend Biotech , Free Report , Capital Management , Services Group , Personalized Indexing Management , Securities Group , Wealth Management , Get Free Report , Bank Aktiengesellschaft , Biotech Corporation , Visit Holdingschannel , Legend Biotech Daily ,